GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » PB Ratio

TCM Biotech International (ROCO:4169) PB Ratio : 3.31 (As of Dec. 14, 2024)


View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-14), TCM Biotech International's share price is NT$58.80. TCM Biotech International's Book Value per Share for the quarter that ended in Jun. 2024 was NT$17.75. Hence, TCM Biotech International's PB Ratio of today is 3.31.

The historical rank and industry rank for TCM Biotech International's PB Ratio or its related term are showing as below:

ROCO:4169' s PB Ratio Range Over the Past 10 Years
Min: 1.68   Med: 2.8   Max: 6.41
Current: 3.31

During the past 13 years, TCM Biotech International's highest PB Ratio was 6.41. The lowest was 1.68. And the median was 2.80.

ROCO:4169's PB Ratio is ranked worse than
61.2% of 1281 companies
in the Biotechnology industry
Industry Median: 2.48 vs ROCO:4169: 3.31

During the past 12 months, TCM Biotech International's average Book Value Per Share Growth Rate was 66.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 20.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 8.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 2.60% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of TCM Biotech International was 36.60% per year. The lowest was -1.10% per year. And the median was 0.80% per year.

Back to Basics: PB Ratio


TCM Biotech International PB Ratio Historical Data

The historical data trend for TCM Biotech International's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International PB Ratio Chart

TCM Biotech International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 3.31 3.55 2.80 3.26

TCM Biotech International Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.84 2.80 6.33 3.26 3.15

Competitive Comparison of TCM Biotech International's PB Ratio

For the Biotechnology subindustry, TCM Biotech International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TCM Biotech International's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TCM Biotech International's PB Ratio distribution charts can be found below:

* The bar in red indicates where TCM Biotech International's PB Ratio falls into.



TCM Biotech International PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

TCM Biotech International's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=58.80/17.749
=3.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


TCM Biotech International  (ROCO:4169) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


TCM Biotech International PB Ratio Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TCM Biotech International Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Section 1, Xintai 5th Road, 24th Floor-8, Xizhi District, Neihu District, Taipei, TWN, 221
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International Headlines

No Headlines